Evidence for a central hypotensive mechanism of 2-(2,6-dichlorophenylamino)-2-imidazoline (Catapresan, ST-155).
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001795:Blood Pressure Determination; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D004285:Dogs; D005260:Female; D007093:Imidazoles / Q000494:pharmacology*; D008297:Male; D010227:Parabiosis; D010477:Perfusion; D013564:Sympathetic Nervous System / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects*
D000959:Antihypertensive Agents; D007093:Imidazoles